Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.

Gao H, Zhang S, Yang Z, Cao S, Jiang X, Pang Z.

Int J Pharm. 2014 May 15;466(1-2):8-17. doi: 10.1016/j.ijpharm.2014.03.012. Epub 2014 Mar 5.

PMID:
24607217
2.

Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.

Gao H, Yang Z, Zhang S, Cao S, Pang Z, Yang X, Jiang X.

J Control Release. 2013 Dec 28;172(3):921-8. doi: 10.1016/j.jconrel.2013.10.002. Epub 2013 Oct 11.

PMID:
24120853
3.

Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis.

Wang B, Lv L, Wang Z, Zhao Y, Wu L, Fang X, Xu Q, Xin H.

Biomaterials. 2014 Jul;35(22):5897-907. doi: 10.1016/j.biomaterials.2014.03.068. Epub 2014 Apr 16.

PMID:
24743033
4.

Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy.

Gao H, Qian J, Yang Z, Pang Z, Xi Z, Cao S, Wang Y, Pan S, Zhang S, Wang W, Jiang X, Zhang Q.

Biomaterials. 2012 Sep;33(26):6264-72. doi: 10.1016/j.biomaterials.2012.05.020. Epub 2012 Jun 8.

PMID:
22683171
5.

Glioma targeting and anti-glioma effect of interleukin 13 peptide and RGD peptide dual functionalized nanoparticles.

Gao H, Hu Y, Xiong Y, Zhang S, Yang J, Yu L, Jiang X.

Curr Pharm Biotechnol. 2014;14(13):1118-26.

PMID:
24016266
6.

LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.

Zhang B, Sun X, Mei H, Wang Y, Liao Z, Chen J, Zhang Q, Hu Y, Pang Z, Jiang X.

Biomaterials. 2013 Dec;34(36):9171-82. doi: 10.1016/j.biomaterials.2013.08.039. Epub 2013 Sep 3.

PMID:
24008043
7.

RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.

Gao H, Xiong Y, Zhang S, Yang Z, Cao S, Jiang X.

Mol Pharm. 2014 Mar 3;11(3):1042-52. doi: 10.1021/mp400751g. Epub 2014 Feb 19.

PMID:
24521297
8.

The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.

Gu G, Gao X, Hu Q, Kang T, Liu Z, Jiang M, Miao D, Song Q, Yao L, Tu Y, Pang Z, Chen H, Jiang X, Chen J.

Biomaterials. 2013 Jul;34(21):5138-48. doi: 10.1016/j.biomaterials.2013.03.036. Epub 2013 Apr 9.

PMID:
23582684
9.

Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles.

Gao H, Qian J, Cao S, Yang Z, Pang Z, Pan S, Fan L, Xi Z, Jiang X, Zhang Q.

Biomaterials. 2012 Jul;33(20):5115-23. doi: 10.1016/j.biomaterials.2012.03.058. Epub 2012 Apr 6.

PMID:
22484043
10.

PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.

Gu G, Xia H, Hu Q, Liu Z, Jiang M, Kang T, Miao D, Tu Y, Pang Z, Song Q, Yao L, Chen H, Gao X, Chen J.

Biomaterials. 2013 Jan;34(1):196-208. doi: 10.1016/j.biomaterials.2012.09.044. Epub 2012 Oct 12.

PMID:
23069707
11.

Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.

Xin H, Sha X, Jiang X, Zhang W, Chen L, Fang X.

Biomaterials. 2012 Nov;33(32):8167-76. doi: 10.1016/j.biomaterials.2012.07.046. Epub 2012 Aug 11.

PMID:
22889488
12.

Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization.

Gao H, Yang Z, Zhang S, Cao S, Shen S, Pang Z, Jiang X.

Sci Rep. 2013;3:2534. doi: 10.1038/srep02534. Erratum in: Sci Rep. 2014;4:5138.

13.

Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.

Wu J, Zhao J, Zhang B, Qian Y, Gao H, Yu Y, Wei Y, Yang Z, Jiang X, Pang Z.

Int J Nanomedicine. 2014 Nov 13;9:5261-71. doi: 10.2147/IJN.S72649. eCollection 2014.

14.

Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, Chen Y, Wang X, Jiang Y, Fang X.

Biomaterials. 2011 Jun;32(18):4293-305. doi: 10.1016/j.biomaterials.2011.02.044. Epub 2011 Mar 21.

PMID:
21427009
15.

Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment.

Gao H, Yang Z, Cao S, Xiong Y, Zhang S, Pang Z, Jiang X.

Biomaterials. 2014 Feb;35(7):2374-82. doi: 10.1016/j.biomaterials.2013.11.076. Epub 2013 Dec 15.

PMID:
24342723
16.

CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels.

Hu Q, Gao X, Kang T, Feng X, Jiang D, Tu Y, Song Q, Yao L, Jiang X, Chen H, Chen J.

Biomaterials. 2013 Dec;34(37):9496-508. doi: 10.1016/j.biomaterials.2013.09.001. Epub 2013 Sep 17.

PMID:
24054848
17.

Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.

Song S, Chen F, Qi H, Li F, Xin T, Xu J, Ye T, Sheng N, Yang X, Pan W.

Pharm Res. 2014 Apr;31(4):1032-45. doi: 10.1007/s11095-013-1225-y. Epub 2013 Oct 24.

PMID:
24154802
18.

PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.

Gu G, Hu Q, Feng X, Gao X, Menglin J, Kang T, Jiang D, Song Q, Chen H, Chen J.

Biomaterials. 2014 Sep;35(28):8215-26. doi: 10.1016/j.biomaterials.2014.06.022. Epub 2014 Jun 25.

PMID:
24974009
19.

In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.

Li X, Tian X, Zhang J, Zhao X, Chen X, Jiang Y, Wang D, Pan W.

Int J Nanomedicine. 2011;6:1167-84. doi: 10.2147/IJN.S21445. Epub 2011 Jun 9.

20.

Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.

Gao H, Zhang S, Cao S, Yang Z, Pang Z, Jiang X.

Mol Pharm. 2014 Aug 4;11(8):2755-63. doi: 10.1021/mp500113p. Epub 2014 Jul 1.

PMID:
24983928
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk